IGF-1LR3

IGF-1 LR3 | IGF-1 Pathway Research Compound

IGF-1 LR3 (Long Arginine 3-IGF-1) is a synthetic analog of human Insulin-like Growth Factor 1 (IGF-1), engineered with structural modifications that provide altered binding characteristics and extended stability compared with native IGF-1. It is studied in controlled laboratory settings for its interactions with IGF-associated receptors, binding proteins, and related cellular signaling pathways.

Key Research Areas:

• IGF-1 Receptor Signaling — IGF-1 LR3 is studied for its interactions with the IGF-1 receptor and associated downstream molecular signaling pathways.
• Cellular Growth Signaling — Laboratory models examine IGF-1 LR3 in relation to cellular proliferation, differentiation, and associated regulatory mechanisms.
• IGF Binding Protein Research — Research investigates the altered binding characteristics of IGF-1 LR3 relative to native IGF-1 and its interactions with IGF-binding proteins.
• Comparative IGF Research — IGF-1 LR3 provides a research model for comparing modified and native IGF-related compounds under controlled experimental conditions.

For laboratory and research use only. Not intended for human or animal consumption, administration, diagnostic, or therapeutic use. Not a drug, dietary supplement, or cosmetic.